Eucalyptus leaf-shaped leaves (Folia Eucalypti viminalis)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Other antimicrobial, antiparasitic and anthelmintic agents

Included in the formulation
  • Eucalyptus tincture
    tincture locally d / inhal. 
    FLORA CAUCASUS, OJSC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    FITO-EM agrarian and industrial firm, CJSC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    LEK S +, LLC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    LEK S +, LLC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    MAGNOLIA SMPP, LLC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    MICROGEN FGUP Scientific and Production Association     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    FITOFARM PKF, LLC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials.
    PHARMACEUTICAL FACTORY of St. Petersburg, JSC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials.
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials.
    St.-MEDIFARM, CJSC     Russia
  • Eucalyptus leaf-shaped leaves
    raw materials. locally d / inhal. 
    FITO-BOT, LLC     Russia
    • АТХ:

    D.08.A.X   Other antiseptics and disinfectants

    Pharmacodynamics:

    Means of plant origin. Water and alcohol extracts from the leaves of eucalyptus are bactericidal, antiviral, fungicidal,antiprotozoal and anti-inflammatory effects. The degree of their expression depends on the content of essential oil (0.3-4.5%).

    The activity of the main component of the essential oil of cineol (65-85%) potentiates pinenes, myrtenol, tannins (up to 6%). When administered orally and in inhalations, eucalyptus preparations cause expectorant, mucolytic and bronchodilator effects, and when applied to the skin, astringent, antiexudative, antipruritic, anesthetic, and in higher concentrations - local irritating effect. Infusion of eucalyptus leaves, due to essential oil and a small amount of bitterness, increases the secretion of digestive glands, improves digestion. When used in the form of a tincture, a sedative effect due to the aldehyde of isovaleric acid is manifested.

    Chlorophyllipt, containing a mixture of chlorophylls from eucalyptus leaves, has antimicrobial, especially antistaphylococcal activity, stimulates regeneration processes. Components of essential oil, together with organic acids, tannins and trace elements, manganese, zinc, selenium increase the resistance of tissues to hypoxia of various genesis.

    Pharmacokinetics:

    Not described.

    Indications:

    Mainly as a part of combined therapy for acute and chronic infectious and inflammatory diseases of the nasopharynx, oral cavity and upper respiratory tract: rhinitis, stomatitis, gingivitis, laryngitis, bronchitis, pneumonia.

    ICD-10

    X.J20-J22.J20   Acute bronchitis

    X.J00-J06.J04   Acute laryngitis and tracheitis

    X.J00-J06.J03   Acute tonsillitis

    X.J00-J06.J02   Acute pharyngitis

    X.J00-J06.J00   Acute nasopharyngitis (runny nose)

    X.J10-J18.J15   Bacterial pneumonia, not elsewhere classified

    X.J40-J47.J42   Chronic bronchitis, unspecified

    X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

    X.J30-J39.J35.0   Chronic tonsillitis

    X.J30-J39.J31   Chronic rhinitis, nasopharyngitis and pharyngitis

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XI.K00-K14.K12   Stomatitis and related lesions

    Contraindications:

    Hypersensitivity to essential oil components and chlorophyllipt, atrophy of the mucous membranes of the upper respiratory tract. Children under 3 years. For inhalations - bronchial asthma, bronchospasm, whooping cough.

    Carefully:

    With caution apply with increased secretion of digestive glands. The safety of prescription of the drug to children under 12 years is not proven.

    Pregnancy and lactation:

    Category of recommendations for FDA is not defined. Adequate and well-controlled studies on humans and animals have not been conducted.The use of the drug during pregnancy is possible only in cases where the intended use for the mother exceeds the potential risk to the fetus and the baby. During lactation, consider the issue of giving up breastfeeding for the duration of the drug.

    Dosing and Administration:

    About 10 grams (2 tablespoons) of crushed leaves are placed in a glass or enamel ware, poured into 200 ml (1 glass) of hot water, covered with a lid and heated in a boiling bath for 15 minutes, cooled at room temperature for 45 minutes, filtered, the remaining raw material squeezed. The volume of the infusion obtained is adjusted to 200 ml with boiled water.

    Apply topically in a warm form for 1/2-1 a glass of infusion: inhalation is carried out 2 times a day, rinsing 3-4 times a day. The course of treatment is 2-3 weeks.

    Before use, the infusion is recommended to shake.

    Side effects:

    Possible: allergic reactions to essential oil components and chlorophyllipt; with frequent and / or prolonged inhalation use - dryness of the mucous membranes of the respiratory system.

    Overdose:

    Cases of overdose are not fixed.

    Interaction:

    Not described.

    Special instructions:

    Do not let eucalyptus (especially tincture, eucalyptus oil, chlorophyllipt) enter the eyes.

    Before the start of treatment, it is necessary to check the sensitivity of the patient to the plant. To do this, give the patient to drink a tablespoon of infusion, 10 drops of tincture or 25 drops of 1% alcohol solution of chlorophyllipt in 1 tablespoon of water. If there are no allergic reactions in 6-8 hours, you can prescribe course treatment. Intolerance can indicate a negative attitude of the patient to the smell of eucalyptus.

    Instructions
    Up